Department of Clinical Pharmacy - Memphis

Fingerprint Dive into the research topics where Department of Clinical Pharmacy - Memphis is active. These topic labels come from the works of this organization's members. Together they form a unique fingerprint.

Candida albicans Medicine & Life Sciences
Critical Illness Medicine & Life Sciences
Parenteral Nutrition Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Drug Interactions Medicine & Life Sciences
Pharmacists Medicine & Life Sciences
Pharmaceutical Preparations Medicine & Life Sciences
Pharmacokinetics Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1974 2019

1 Citation (Scopus)

Abrogation of Triazole Resistance upon Deletion of CDR1 in a Clinical Isolate of Candida auris

Rybak, J. M., Doorley, L. A., Nishimoto, A. T., Barker, K. S., Palmer, G. & Rogers, P., Apr 1 2019, In : Antimicrobial Agents and Chemotherapy. e00057-19.

Research output: Contribution to journalArticle

Triazoles
Candida
Candida albicans
Genome
Delivery of Health Care

Adjusted versus actual body weight dosing of 4-factor prothrombin complex concentrate in obese patients with warfarin-associated major bleeding

Smetana, K. S., Ziemba, R., May, C. C., Erdman, M. J., Van Matre, E. & Jones, G. M., Apr 15 2019, In : Journal of Thrombosis and Thrombolysis. 47, 3, p. 369-374 6 p.

Research output: Contribution to journalArticle

Warfarin
Body Weight
Hemorrhage
International Normalized Ratio
Product Labeling
7 Citations (Scopus)

A New Option for Reversing the Anticoagulant Effect of Factor Xa Inhibitors: Andexanet Alfa (ANDEXXA)

Rogers, K. & Finks, S., Jan 1 2019, In : American Journal of Medicine. 132, 1, p. 38-41 4 p.

Research output: Contribution to journalReview article

Anticoagulants
United States Food and Drug Administration
Factor Xa
Antithrombins
Warfarin